J.W. Cole Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.03M | Buy |
36,547
+540
| +1% | +$44.8K | 0.06% | 289 |
|
|
2025
Q1 | $2.92M | Sell |
36,007
-1,187
| -3% | -$96.3K | 0.09% | 230 |
|
|
2024
Q4 | $3.35M | Buy |
37,194
+1,450
| +4% | +$131K | 0.14% | 152 |
|
|
2024
Q3 | $3.53M | Sell |
35,744
-540
| -1% | -$53.4K | 0.15% | 140 |
|
|
2024
Q2 | $3.36M | Buy |
36,284
+279
| +0.8% | +$25.9K | 0.16% | 137 |
|
|
2024
Q1 | $3.42M | Buy |
36,005
+826
| +2% | +$78.4K | 0.17% | 131 |
|
|
2023
Q4 | $3.14M | Sell |
35,179
-2,499
| -7% | -$223K | 0.18% | 128 |
|
|
2023
Q3 | $2.75M | Sell |
37,678
-382
| -1% | -$27.9K | 0.2% | 120 |
|
|
2023
Q2 | $3.17M | Buy |
38,060
+781
| +2% | +$65K | 0.23% | 106 |
|
|
2023
Q1 | $2.84M | Buy |
37,279
+542
| +1% | +$41.3K | 0.2% | 126 |
|
|
2022
Q4 | $3.05M | Sell |
36,737
-5,440
| -13% | -$452K | 0.23% | 111 |
|
|
2022
Q3 | $3.35M | Buy |
42,177
+5,221
| +14% | +$414K | 0.28% | 83 |
|
|
2022
Q2 | $2.75M | Buy |
36,956
+13,728
| +59% | +$1.02M | 0.22% | 115 |
|
|
2022
Q1 | $2.09M | Buy |
23,228
+5,638
| +32% | +$507K | 0.14% | 171 |
|
|
2021
Q4 | $1.97M | Sell |
17,590
-279,568
| -94% | -$31.3M | 0.13% | 183 |
|
|
2021
Q3 | $22.5M | Buy |
297,158
+285,035
| +2,351% | +$21.6M | 1.61% | 10 |
|
|
2021
Q2 | $1.64M | Sell |
12,123
-314
| -3% | -$42.5K | 0.13% | 185 |
|
|
2021
Q1 | $1.69M | Sell |
12,437
-601
| -5% | -$81.5K | 0.16% | 154 |
|
|
2020
Q4 | $1.84M | Buy |
13,038
+8,089
| +163% | +$1.14M | 0.19% | 128 |
|
|
2020
Q3 | $551K | Sell |
4,949
-8,797
| -64% | -$979K | 0.04% | 399 |
|
|
2020
Q2 | $1.54M | Buy |
+13,746
| New | +$1.54M | 0.23% | 120 |
|
|
2020
Q1 | – | Sell |
-6,456
| Closed | -$614K | – | 518 |
|
|
2019
Q4 | $614K | Buy |
+6,456
| New | +$614K | 0.08% | 266 |
|